ACHC

Acadia Healthcare Company, Inc.

Fundamental data last updated:May 15, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Care Facilities

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

08/04/2026

Business Summary

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.

 


Analyze ACHC on TradingView

VALUATION

P/E

-2.22

Market Cap ($M USD)

$2.50B

Forward P/E

12.57

PEG

0.11

PRICE TO SALES

0.74

PRICE TO BOOK

1.26

EV / EBITDA

-7.25

5-Year Average P/E

Free Cash Flow Yield

-11.69%

DCF Value

$-127.78

Graham Number

N/A

Price to FCF

-8.56

EV to FCF

-17.16

Earnings Yield

-45.04%

FCF Yield

-11.69%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

-$12.23

Next Year EPS Growth Estimate

$2.16

Next Year Revenue Growth Estimate

$417.09B

Return on Equity (ROE)

-43.82%

FREE CASH FLOW

Operating Margin

11.67%

Debt-to-Equity

1.36

Piotroski F-Score

5

Altman Z-Score

0.39

Return on Invested Capital (ROIC)

7.78%

Current Ratio

1.71

Quick Ratio

1.70

Net Debt to EBITDA

-3.63

Interest Coverage

2.66

Gross Profit margin

56.21%

FCF PER SHARE

$-3.22

REVENUE PER SHARE

$37.24

Analyze ACHC on TradingView

Gainseekers Quantitative Analysis

Summary

The market’s current valuation of Acadia Healthcare Company, Inc. seems to be a stark mispricing when juxtaposed with its DCF Value, which is deeply negative. The Forward P/E of 11.66 suggests optimism about future earnings, yet the negative Earnings Yield and Altman Z-score of 0.37 raise red flags about financial distress and potential insolvency risks. The Price/Book ratio of 1.16 indicates a modest premium over book value, but the negative Price to FCF ratio highlights severe cash flow issues. Overall, the financial health appears precarious, with the market perhaps overlooking significant underlying risks.

AI Exposure / Tech Reliance

In the healthcare sector, Acadia is positioned to leverage AI for operational efficiencies, particularly in patient care management and data analytics. However, the industry’s slow adoption of tech innovations could be a hurdle. Acadia's ability to integrate AI effectively will be crucial for maintaining a competitive edge.

The Bull Case

For a value or GARP investor, Acadia presents an intriguing opportunity. The ROIC of 7.78% indicates efficient capital use, while the Piotroski F-Score of 5 suggests moderate financial health. Despite a negative FCF Yield, the operating margin of 11.67% reflects solid pricing power. These metrics hint at a company with potential for improved profitability and capital efficiency, making it a candidate for those betting on a turnaround.

The Bear Case

The bear case for Acadia is compelling. The negative EPS and a Return on Equity of -43.82% are glaring indicators of poor profitability and management inefficiency. The stock's proximity to its 52-week high, coupled with a Price/Sales ratio of 0.69, suggests it may be technically overextended. Additionally, the negative Net Debt to EBITDA ratio underscores severe leverage issues, painting a picture of a company struggling to generate sufficient cash flow to cover its debts.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$25.59

Institutional Ownership %

1-Year Beta

0.73

Insider Buying % (6 Mo)

Distance to 52-Week High

11.23%

Distance to 52-Week Low

57.90%

EARNINGS SURPRISE %

32.14%

50-DAY SMA

$25.34

200-DAY SMA

$20.48

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.